[(2E,5R,9R)-2-hexa-2,4-diynylidene-1,6-dioxaspiro[4.4]nona-3,7-dien-9-yl] acetate

Details

Top
Internal ID cce8fdc9-fee6-414f-a24d-7be9e75312d7
Taxonomy Organic oxygen compounds > Organooxygen compounds > Ethers > Acetals > Ketals
IUPAC Name [(2E,5R,9R)-2-hexa-2,4-diynylidene-1,6-dioxaspiro[4.4]nona-3,7-dien-9-yl] acetate
SMILES (Canonical) CC#CC#CC=C1C=CC2(O1)C(C=CO2)OC(=O)C
SMILES (Isomeric) CC#CC#C/C=C/1\C=C[C@@]2(O1)[C@@H](C=CO2)OC(=O)C
InChI InChI=1S/C15H12O4/c1-3-4-5-6-7-13-8-10-15(19-13)14(9-11-17-15)18-12(2)16/h7-11,14H,1-2H3/b13-7+/t14-,15-/m1/s1
InChI Key XQVRVLVORPSYNU-PHIGAYBXSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H12O4
Molecular Weight 256.25 g/mol
Exact Mass 256.07355886 g/mol
Topological Polar Surface Area (TPSA) 44.80 Ų
XlogP 2.20
Atomic LogP (AlogP) 1.66
H-Bond Acceptor 4
H-Bond Donor 0
Rotatable Bonds 1

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(2E,5R,9R)-2-hexa-2,4-diynylidene-1,6-dioxaspiro[4.4]nona-3,7-dien-9-yl] acetate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9631 96.31%
Caco-2 + 0.5874 58.74%
Blood Brain Barrier + 0.7500 75.00%
Human oral bioavailability - 0.5429 54.29%
Subcellular localzation Mitochondria 0.6360 63.60%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9130 91.30%
OATP1B3 inhibitior + 0.9064 90.64%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior - 0.9500 95.00%
BSEP inhibitior - 0.6195 61.95%
P-glycoprotein inhibitior - 0.8861 88.61%
P-glycoprotein substrate - 0.8143 81.43%
CYP3A4 substrate + 0.6094 60.94%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8788 87.88%
CYP3A4 inhibition - 0.7206 72.06%
CYP2C9 inhibition - 0.9430 94.30%
CYP2C19 inhibition - 0.7614 76.14%
CYP2D6 inhibition - 0.9146 91.46%
CYP1A2 inhibition - 0.7347 73.47%
CYP2C8 inhibition - 0.6784 67.84%
CYP inhibitory promiscuity - 0.6083 60.83%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8700 87.00%
Carcinogenicity (trinary) Non-required 0.3787 37.87%
Eye corrosion - 0.7392 73.92%
Eye irritation - 0.7079 70.79%
Skin irritation - 0.6633 66.33%
Skin corrosion - 0.9141 91.41%
Ames mutagenesis - 0.5300 53.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6281 62.81%
Micronuclear + 0.5200 52.00%
Hepatotoxicity - 0.5122 51.22%
skin sensitisation - 0.5955 59.55%
Respiratory toxicity - 0.5889 58.89%
Reproductive toxicity + 0.5111 51.11%
Mitochondrial toxicity - 0.5750 57.50%
Nephrotoxicity + 0.7827 78.27%
Acute Oral Toxicity (c) III 0.4694 46.94%
Estrogen receptor binding + 0.7991 79.91%
Androgen receptor binding + 0.6047 60.47%
Thyroid receptor binding + 0.6537 65.37%
Glucocorticoid receptor binding + 0.6438 64.38%
Aromatase binding + 0.7366 73.66%
PPAR gamma + 0.6669 66.69%
Honey bee toxicity - 0.6721 67.21%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.5455 54.55%
Fish aquatic toxicity + 0.7731 77.31%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 94.99% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 91.92% 96.09%
CHEMBL3401 O75469 Pregnane X receptor 88.69% 94.73%
CHEMBL1293249 Q13887 Kruppel-like factor 5 83.37% 86.33%
CHEMBL1806 P11388 DNA topoisomerase II alpha 83.15% 89.00%
CHEMBL2581 P07339 Cathepsin D 82.19% 98.95%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 81.23% 99.23%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 80.15% 94.45%

Cross-Links

Top
PubChem 92269932
NPASS NPC308718
LOTUS LTS0213775
wikiData Q105340093